ultrasound contrast agent detection
Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events
7
Molecular imaging modalities using nanoprobes for cancer diagnosis
26
Immunological evaluation of the new stable ultrasound contrast agent LK565: a phase one clinical trial
8
Ultrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound Agent
13
Contrast-Enhanced Ultrasound Imaging for the Detection of Focused Ultrasound-Induced Blood-Brain Barrier Opening
12
Doppler ultrasound imaging techniques for assessment of synovial inflammation
9
Endocavitary contrast enhanced ultrasound (CEUS): a novel problem solving technique
9
Targeted delivery of reduced graphene oxide nanosheets using multifunctional ultrasound nanobubbles for visualization and enhanced photothermal therapy
14
State-of-the-art cross-sectional liver imaging: beyond lesion detection and characterization
17
Fe3O4@Ag Nanoprobe for Detection of Ovarian Cancer Cell Line Using Magnetic Resonance Imaging
10
Effects of ultrasound and ultrasound contrast agent on vascular tissue
10
Detection of vascularity in wrist tenosynovitis: power doppler ultrasound compared with contrast enhanced grey scale ultrasound
8
Early detection of osteoarthritis in rabbits using MRI with a double contrast agent
9
Visualizing arthritic inflammation and therapeutic response by fluorine-19 magnetic resonance imaging (19F MRI)
10
Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro
11
Advances in the field of nanooncology
11
Near infrared planar tumor imaging and quantification using nanosized Alexa 750-labeled phospholipid micelles
9
A Novel Contrast Agent Based on Magnetic Nanoparticles for Cholesterol Detection as Alzheimer’s Disease Biomarker
6
Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agent
14
Developing a contrast agent for the in vivo detection of apoptosis
92